# Efficacy of Oral Zinc Administration as an Adjunct Therapy in New Pulmonary Tuberculosis (Category I) Patients

> **NCT00698386** · PHASE3 · UNKNOWN · sponsor: **Ministry of Science and Technology, India** · enrollment: 150 (estimated)

## Conditions studied

- Pulmonary Tuberculosis

## Interventions

- **DIETARY_SUPPLEMENT:** Zinc supplement
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT00698386
- **Lead sponsor:** Ministry of Science and Technology, India
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-02
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2009-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00698386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00698386, "Efficacy of Oral Zinc Administration as an Adjunct Therapy in New Pulmonary Tuberculosis (Category I) Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00698386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*